Hoth Therapeutics Inc (NASDAQ: HOTH) is pleased to announce its Cohort 1 results. This trial happens to be the first time this patient-focused Biopharmaceutical Company is engaging in a clinical trial focused on eczema treatment.  Focusing on the results The other name for the condition mentioned above is atopic dermatitis. It […]